|
|
DF/HCC News
Cell Manipulation Core Facility The Cell Manipulation Core Facility (CMCF) produces safe and effective cellular components for subjects enrolled in novel therapeutic clinical research protocols
Eleven new members join DF/HCC Eleven individuals have recently joined DF/HCC
DF/HCC-led trials aim to overcome resistance in metastatic GIST Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract
Cells to Society: New centers explore two major areas of cancer disparities The earlier onset, higher rates, and worse outcomes of cancer in poor and minority populations in the United States may be well documented, but they are not well understood
Major study tests primary prevention power of vitamin D and omega-3s Television news and cereal boxes tout the health benefits of extra vitamin D and omega-3 fatty acids, but exceeding the recommended dietary allowance of either is not a proven way to prevent cancer nor cardiovascular di
Phase II study tests exercise, metformin in colorectal cancer survivors Nearly 150,000 people are diagnosed with colorectal cancer every year in the United States, leading to approximately 50,000 deaths from the disease
Media matters for more than health disparities Most people — including the public, patients, physicians, and policy makers — rely on the news media to translate research discoveries into useful information
Displaying results 29 to 35 out of 184
|
